Evidence map›Paper›PMID 27753502›Full record

ReviewAmerican journal of respiratory and critical care medicine2017

Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy.

Jason J Rose, Ling Wang, Qinzi Xu, Charles F McTiernan, Sruti Shiva, Jesus Tejero, Mark T Gladwin

Erratum issued Registry-linked trialAbstract readReview
In one paragraph

Review in American journal of respiratory and critical care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03818841 (High-flow Nasal Cannula Therapy in the Treatment of Acute Carbon Monoxide Poisoning), which is not on this map. Cited by 305 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
305citing papers in PubMed, 4 pooled it
23.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03818841 naunknown statusnot on this mapstarted 2019, after this paper: background citation

High-flow Nasal Cannula Therapy in the Treatment of Acute Carbon Monoxide Poisoning

TypeinterventionalSponsorUniversità degli Studi del Piemonte Orientale Amedeo AvogadroRan2019 to 2022Enrolled96ConditionsCarbon Monoxide PoisoningArmsHigh-flow nasal cannula device, Non-rebreathing oxygen mask group
3 · Its place in the literature

Who cites it

305 citing papers in PubMed, 4 syntheses or guidelines pooled it, 803 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Helicopter emergency medical services for interfacility transfers: an Italian expert consensus.Scandinavian journal of trauma, resuscitation and emergency medicine · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article

245 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jason J Rose1 Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute.ORCID 0000-0003-1347-9148
Ling Wang1 Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute.ORCID 0000-0003-4333-3158
Qinzi Xu1 Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute.
Charles F McTiernan1 Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute.ORCID 0000-0001-9057-4021
Sruti Shiva1 Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute.
Jesus Tejero1 Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute.ORCID 0000-0003-3245-9978
Mark T Gladwin1 Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute.
Pulmonary and Allergy Associates · USNational Heart Lung and Blood Institute · USUniversity of Pittsburgh · US

Funding

Carbon Monoxide Inhibition of Mitochondrial Function and Efficacy of a Novel Antidotal Therapeutic for Carbon Monoxide PoisoningF32HL132418 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROSE, JASON J · 2016 to 2017
$97k
NHLBI NIH HHS F32 HL132418
6 · The paper itself

Abstract

Carbon monoxide (CO) poisoning affects 50,000 people a year in the United States. The clinical presentation runs a spectrum, ranging from headache and dizziness to coma and death, with a mortality rate ranging from 1 to 3%. A significant number of patients who survive CO poisoning suffer from long-term neurological and affective sequelae. The neurologic deficits do not necessarily correlate with blood CO levels but likely result from the pleiotropic effects of CO on cellular mitochondrial respiration, cellular energy utilization, inflammation, and free radical generation, especially in the brain and heart. Long-term neurocognitive deficits occur in 15-40% of patients, whereas approximately one-third of moderate to severely poisoned patients exhibit cardiac dysfunction, including arrhythmia, left ventricular systolic dysfunction, and myocardial infarction. Imaging studies reveal cerebral white matter hyperintensities, with delayed posthypoxic leukoencephalopathy or diffuse brain atrophy. Management of these patients requires the identification of accompanying drug ingestions, especially in the setting of intentional poisoning, fire-related toxic gas exposures, and inhalational injuries. Conventional therapy is limited to normobaric and hyperbaric oxygen, with no available antidotal therapy. Although hyperbaric oxygen significantly reduces the permanent neurological and affective effects of CO poisoning, a portion of survivors still have substantial morbidity. There has been some early success in therapies targeting the downstream inflammatory and oxidative effects of CO poisoning. New methods to directly target the toxic effect of CO, such as CO scavenging agents, are currently under development.

Indexed as

Carbon Monoxide PoisoningHumansHyperbaric Oxygenationcarbon monoxidecarbon monoxide poisoningmitochondria

Identifiers

PMID27753502
PMCPMC5363978
OpenAlexW2532034722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.